{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:32:32Z","timestamp":1788381152544,"version":"build-2803163510"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T00:00:00Z","timestamp":1554508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["019R1A2C1009231"],"award-info":[{"award-number":["019R1A2C1009231"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["370C-20160062"],"award-info":[{"award-number":["370C-20160062"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2011-0030001"],"award-info":[{"award-number":["2011-0030001"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s12272-019-01150-z","type":"journal-article","created":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T03:16:15Z","timestamp":1554606975000},"page":"629-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Natural compound inducers of immunogenic cell death"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4725","authenticated-orcid":false,"given":"Marc","family":"Diederich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,6]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"publisher","first-page":"e968434","DOI":"10.4161\/21624011.2014.968434","volume":"3","author":"I Adkins","year":"2014","unstructured":"Adkins I, Fucikova J, Garg AD, Agostinis P, Spisek R (2014) Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology 3:e968434","journal-title":"Oncoimmunology"},{"key":"1150_CR2","first-page":"7774","volume":"15","author":"FM Arcamone","year":"2009","unstructured":"Arcamone FM (2009) Fifty years of chemical research at Farmitalia. Chemistry (Easton) 15:7774\u20137791","journal-title":"Chemistry (Easton)"},{"key":"1150_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1039\/C8BM01403E","volume":"7","author":"I Banerjee","year":"2019","unstructured":"Banerjee I, De M, Dey G, Bharti R, Chattopadhyay S, Ali N, Chakrabarti P, Reis RL, Kundu SC, Mandal M (2019) A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model. Biomater Sci 7:1161\u20131178","journal-title":"Biomater Sci"},{"key":"1150_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","volume":"25","author":"L Bezu","year":"2018","unstructured":"Bezu L, Sauvat A, Humeau J, Gomes-Da-Silva LC, Iribarren K, Forveille S, Garcia P, Zhao L, Liu P, Zitvogel L, Senovilla L, Kepp O, Kroemer G (2018) eIF2alpha phosphorylation is pathognomonic for immunogenic cell death. Cell Death Differ 25:1375\u20131393","journal-title":"Cell Death Differ"},{"key":"1150_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1124\/mol.109.056259","volume":"76","author":"JY Byun","year":"2009","unstructured":"Byun JY, Kim MJ, Eum DY, Yoon CH, Seo WD, Park KH, Hyun JW, Lee YS, Lee JS, Yoon MY, Lee SJ (2009) Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells. Mol Pharmacol 76:734\u2013744","journal-title":"Mol Pharmacol"},{"key":"1150_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13058-018-1092-x","volume":"21","author":"KA Camilio","year":"2019","unstructured":"Camilio KA, Wang MY, Mauseth B, Waagene S, Kvalheim G, Rekdal O, Sveinbjornsson B, Maelandsmo GM (2019) Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model. Breast Cancer Res 21:9","journal-title":"Breast Cancer Res"},{"key":"1150_CR7","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1084\/jem.20050915","volume":"202","author":"N Casares","year":"2005","unstructured":"Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Metivier D, Pichard E, Aucouturier P, Pierron G, Garrido C, Zitvogel L, Kroemer G (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202:1691\u20131701","journal-title":"J Exp Med"},{"key":"1150_CR8","doi-asserted-by":"publisher","first-page":"e1498285","DOI":"10.1080\/2162402X.2018.1498285","volume":"8","author":"F Castoldi","year":"2019","unstructured":"Castoldi F, Vacchelli E, Zitvogel L, Maiuri MC, Pietrocola F, Kroemer G (2019) Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. Oncoimmunology 8:e1498285","journal-title":"Oncoimmunology"},{"key":"1150_CR9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.biotechadv.2014.03.006","volume":"32","author":"C Cerella","year":"2014","unstructured":"Cerella C, Teiten MH, Radogna F, Dicato M, Diederich M (2014) From nature to bedside: pro-survival and cell death mechanisms as therapeutic targets in cancer treatment. Biotechnol Adv 32:1111\u20131122","journal-title":"Biotechnol Adv"},{"key":"1150_CR10","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1128\/AAC.47.9.2810-2816.2003","volume":"47","author":"X Chen","year":"2003","unstructured":"Chen X, Yang L, Zhang N, Turpin JA, Buckheit RW, Osterling C, Oppenheim JJ, Howard OM (2003) Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother 47:2810\u20132816","journal-title":"Antimicrob Agents Chemother"},{"key":"1150_CR11","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-012-1258-9","volume":"61","author":"HM Chen","year":"2012","unstructured":"Chen HM, Wang PH, Chen SS, Wen CC, Chen YH, Yang WC, Yang NS (2012) Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunol Immunother 61:1989\u20132002","journal-title":"Cancer Immunol Immunother"},{"key":"1150_CR12","doi-asserted-by":"publisher","first-page":"e26198","DOI":"10.4161\/onci.26198","volume":"2","author":"M Cirone","year":"2013","unstructured":"Cirone M, Garufi A, Di Renzo L, Granato M, Faggioni A, D\u2019orazi G (2013) Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells. Oncoimmunology 2:e26198","journal-title":"Oncoimmunology"},{"key":"1150_CR13","doi-asserted-by":"publisher","first-page":"e2108","DOI":"10.1038\/cddis.2016.29","volume":"7","author":"T Colangelo","year":"2016","unstructured":"Colangelo T, Polcaro G, Ziccardi P, Muccillo L, Galgani M, Pucci B, Milone MR, Budillon A, Santopaolo M, Mazzoccoli G, Matarese G, Sabatino L, Colantuoni V (2016) The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells. Cell Death Dis 7:e2108","journal-title":"Cell Death Dis"},{"issue":"Suppl 2","key":"1150_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000443404","volume":"25","author":"GM Cragg","year":"2016","unstructured":"Cragg GM, Pezzuto JM (2016) Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract 25(Suppl 2):41\u201359","journal-title":"Med Princ Pract"},{"key":"1150_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jphotobiol.2008.01.011","volume":"91","author":"LM Davids","year":"2008","unstructured":"Davids LM, Kleemann B, Kacerovska D, Pizinger K, Kidson SH (2008) Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. J Photochem Photobiol B 91:67\u201376","journal-title":"J Photochem Photobiol B"},{"key":"1150_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12192-013-0422-2","volume":"18","author":"D D\u2019eliseo","year":"2013","unstructured":"D\u2019eliseo D, Manzi L, Velotti F (2013) Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells. Cell Stress Chaperones 18:801\u2013808","journal-title":"Cell Stress Chaperones"},{"key":"1150_CR17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.18632\/genesandcancer.131","volume":"8","author":"D D\u2019eliseo","year":"2017","unstructured":"D\u2019eliseo D, Di Renzo L, Santoni A, F Velotti (2017) Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells. Genes Cancer 8:426\u2013437","journal-title":"Genes Cancer"},{"key":"1150_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2016.06.001","volume":"40\u201341","author":"M Diederich","year":"2016","unstructured":"Diederich M, Cerella C (2016) Non-canonical programmed cell death mechanisms triggered by natural compounds. Semin Cancer Biol 40\u201341:4\u201334","journal-title":"Semin Cancer Biol"},{"key":"1150_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.08.017","volume":"125","author":"M Diederich","year":"2017","unstructured":"Diederich M, Muller F, Cerella C (2017) Cardiac glycosides: from molecular targets to immunogenic cell death. Biochem Pharmacol 125:1\u201311","journal-title":"Biochem Pharmacol"},{"key":"1150_CR20","doi-asserted-by":"publisher","first-page":"7387","DOI":"10.1021\/acs.nanolett.7b03218","volume":"17","author":"Y Fan","year":"2017","unstructured":"Fan Y, Kuai R, Xu Y, Ochyl LJ, Irvine DJ, Moon JJ (2017) Immunogenic cell death amplified by co-localized adjuvant delivery for cancer immunotherapy. Nano Lett 17:7387\u20137393","journal-title":"Nano Lett"},{"key":"1150_CR21","first-page":"1549","volume":"25","author":"H Fredly","year":"2011","unstructured":"Fredly H, Ersvaer E, Gjertsen BT, Bruserud O (2011) Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis. Oncol Rep 25:1549\u20131556","journal-title":"Oncol Rep"},{"key":"1150_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G (2017) Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 17:97\u2013111","journal-title":"Nat Rev Immunol"},{"key":"1150_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00262-011-1184-2","volume":"61","author":"AD Garg","year":"2012","unstructured":"Garg AD, Krysko DV, Vandenabeele P, Agostinis P (2012) Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother 61:215\u2013221","journal-title":"Cancer Immunol Immunother"},{"key":"1150_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/biof.1125","volume":"39","author":"AD Garg","year":"2013","unstructured":"Garg AD, Dudek AM, Agostinis P (2013a) Cancer immunogenicity, danger signals, and DAMPs: what, when, and how? BioFactors 39:355\u2013367","journal-title":"BioFactors"},{"key":"1150_CR25","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4161\/auto.25399","volume":"9","author":"AD Garg","year":"2013","unstructured":"Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, Mathieu C, Agostinis P (2013b) ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 9:1292\u20131307","journal-title":"Autophagy"},{"key":"1150_CR26","doi-asserted-by":"publisher","first-page":"26841","DOI":"10.18632\/oncotarget.4754","volume":"6","author":"AD Garg","year":"2015","unstructured":"Garg AD, Elsen S, Krysko DV, Vandenabeele P, De Witte P, Agostinis P (2015) Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. Oncotarget 6:26841\u201326860","journal-title":"Oncotarget"},{"key":"1150_CR27","doi-asserted-by":"publisher","first-page":"328ra327","DOI":"10.1126\/scitranslmed.aae0105","volume":"8","author":"AD Garg","year":"2016","unstructured":"Garg AD, Vandenberk L, Koks C, Verschuere T, Boon L, Van Gool SW, Agostinis P (2016) Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma. Sci Transl Med 8:328ra327","journal-title":"Sci Transl Med"},{"key":"1150_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jconrel.2018.12.022","volume":"294","author":"M Garofalo","year":"2019","unstructured":"Garofalo M, Villa A, Rizzi N, Kuryk L, Rinner B, Cerullo V, Yliperttula M, Mazzaferro V, Ciana P (2019) Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. J Control Release 294:165\u2013175","journal-title":"J Control Release"},{"key":"1150_CR29","doi-asserted-by":"publisher","first-page":"e1466765","DOI":"10.1080\/2162402X.2018.1466765","volume":"7","author":"P Giglio","year":"2018","unstructured":"Giglio P, Gagliardi M, Tumino N, Antunes F, Smaili S, Cotella D, Santoro C, Bernardini R, Mattei M, Piacentini M, Corazzari M (2018) PKR and GCN2 stress kinases promote an ER stress-independent eIF2alpha phosphorylation responsible for calreticulin exposure in melanoma cells. Oncoimmunology 7:e1466765","journal-title":"Oncoimmunology"},{"key":"1150_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/ard.12.1.16","volume":"12","author":"W Graham","year":"1953","unstructured":"Graham W, Roberts JB (1953) Intravenous colchicine in the management of gouty arthritis. Ann Rheum Dis 12:16\u201319","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1150_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1351\/pac198658050701","volume":"58","author":"Y Hirata","year":"1986","unstructured":"Hirata Y, Uemura D (1986) Halichondrins\u2014antitumor polyether macrolides from a marine sponge. Pure Appl Chem 58(5):701","journal-title":"Pure Appl Chem"},{"key":"1150_CR32","doi-asserted-by":"publisher","first-page":"e1446720","DOI":"10.1080\/2162402X.2018.1446720","volume":"7","author":"FY Huang","year":"2018","unstructured":"Huang FY, Lei J, Sun Y, Yan F, Chen B, Zhang L, Lu Z, Cao R, Lin YY, Wang CC, Tan GH (2018) Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes. Oncoimmunology 7:e1446720","journal-title":"Oncoimmunology"},{"key":"1150_CR33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3892\/etm.2014.1489","volume":"7","author":"S Inoue","year":"2014","unstructured":"Inoue S, Setoyama Y, Odaka A (2014) Doxorubicin treatment induces tumor cell death followed by immunomodulation in a murine neuroblastoma model. Exp Ther Med 7:703\u2013708","journal-title":"Exp Ther Med"},{"key":"1150_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2017.12.011","volume":"416","author":"S Ji","year":"2018","unstructured":"Ji S, Lee JY, Schror J, Mazumder A, Jang DM, Chateauvieux S, Schnekenburger M, Hong CR, Christov C, Kang HJ, Lee Y, Han BW, Kim KW, Shin HY, Dicato M, Cerella C, Konig GM, Orlikova B, Diederich M (2018) The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer. Cancer Lett 416:109\u2013123","journal-title":"Cancer Lett"},{"key":"1150_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3892\/etm.2016.3368","volume":"12","author":"T Jin","year":"2016","unstructured":"Jin T, Wu H, Wang Y, Peng H (2016) Capsaicin induces immunogenic cell death in human osteosarcoma cells. Exp Ther Med 12:765\u2013770","journal-title":"Exp Ther Med"},{"key":"1150_CR36","doi-asserted-by":"publisher","first-page":"15920","DOI":"10.1038\/s41598-017-15674-1","volume":"7","author":"MP Johansson","year":"2017","unstructured":"Johansson MP, Maaheimo H, Ekholm FS (2017) New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling. Sci Rep 7:15920","journal-title":"Sci Rep"},{"key":"1150_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1381612053382287","volume":"11","author":"A Kubin","year":"2005","unstructured":"Kubin A, Wierrani F, Burner U, Alth G, Grunberger W (2005) Hypericin\u2013the facts about a controversial agent. Curr Pharm Des 11:233\u2013253","journal-title":"Curr Pharm Des"},{"key":"1150_CR38","doi-asserted-by":"publisher","DOI":"10.26717\/BJSTR.2017.01.000571","author":"SS Kumar","year":"2017","unstructured":"Kumar SS (2017) Maytenus ovatus (schweinf.) An African medicinal plant yielding potential anti-cancer drugs. Biomed J Sci Tech Res. https:\/\/doi.org\/10.26717\/BJSTR.2017.01.000571","journal-title":"Biomed J Sci Tech Res"},{"key":"1150_CR39","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1021\/ja00759a054","volume":"94","author":"SM Kupchan","year":"1972","unstructured":"Kupchan SM, Komoda Y, Court WA, Thomas GJ, Smith RM, Karim A, Gilmore CJ, Haltiwanger RC, Bryan RF (1972) Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J Am Chem Soc 94:1354\u20131356","journal-title":"J Am Chem Soc"},{"key":"1150_CR40","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1080\/15548627.2015.1082022","volume":"11","author":"S Ladoire","year":"2015","unstructured":"Ladoire S, Penault-Llorca F, Senovilla L, Dalban C, Enot D, Locher C, Prada N, Poirier-Colame V, Chaba K, Arnould L, Ghiringhelli F, Fumoleau P, Spielmann M, Delaloge S, Poillot ML, Arveux P, Goubar A, Andre F, Zitvogel L, Kroemer G (2015) Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy 11:1878\u20131890","journal-title":"Autophagy"},{"key":"1150_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.canlet.2017.12.007","volume":"416","author":"JY Lee","year":"2018","unstructured":"Lee JY, Talhi O, Jang D, Cerella C, Gaigneaux A, Kim KW, Lee JW, Dicato M, Bachari K, Han BW, Silva AMS, Orlikova B, Diederich M (2018) Cytostatic hydroxycoumarin OT52 induces ER\/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer. Cancer Lett 416:94\u2013108","journal-title":"Cancer Lett"},{"key":"1150_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biomaterials.2018.07.035","volume":"181","author":"TF Li","year":"2018","unstructured":"Li TF, Li K, Zhang Q, Wang C, Yue Y, Chen Z, Yuan SJ, Liu X, Wen Y, Han M, Komatsu N, Xu YH, Zhao L, Chen X (2018) Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma. Biomaterials 181:35\u201352","journal-title":"Biomaterials"},{"key":"1150_CR43","doi-asserted-by":"publisher","first-page":"e0138335","DOI":"10.1371\/journal.pone.0138335","volume":"10","author":"TJ Lin","year":"2015","unstructured":"Lin TJ, Liang WM, Hsiao PW, SP M, Wei WC, Lin HT, Yin SY, Yang NS (2015) Rapamycin promotes mouse 4T1 tumor metastasis that can be reversed by a dendritic cell-based vaccine. PLoS ONE 10:e0138335","journal-title":"PLoS ONE"},{"key":"1150_CR44","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1080\/15548627.2017.1386359","volume":"14","author":"SY Lin","year":"2018","unstructured":"Lin SY, Hsieh SY, Fan YT, Wei WC, Hsiao PW, Tsai DH, Wu TS, Yang NS (2018) Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance. Autophagy 14:778\u2013795","journal-title":"Autophagy"},{"key":"1150_CR45","doi-asserted-by":"publisher","first-page":"14915","DOI":"10.1038\/s41598-017-14848-1","volume":"7","author":"P Liu","year":"2017","unstructured":"Liu P, Zhao L, Loos F, Iribarren K, Lachkar S, Zhou H, Gomes-Da-Silva LC, Chen G, Bezu L, Boncompain G, Perez F, Zitvogel L, Kepp O, Kroemer G (2017) Identification of pharmacological agents that induce HMGB1 release. Sci Rep 7:14915","journal-title":"Sci Rep"},{"key":"1150_CR46","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1021\/acsnano.8b01890","volume":"12","author":"Q Liu","year":"2018","unstructured":"Liu Q, Chen F, Hou L, Shen L, Zhang X, Wang D, Huang L (2018a) Nanocarrier-mediated chemo-immunotherapy arrested cancer progression and induced tumor dormancy in desmoplastic melanoma. ACS Nano 12:7812\u20137825","journal-title":"ACS Nano"},{"key":"1150_CR47","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1021\/acsnano.7b07384","volume":"12","author":"Q Liu","year":"2018","unstructured":"Liu Q, Zhu H, Tiruthani K, Shen L, Chen F, Gao K, Zhang X, Hou L, Wang D, Liu R, Huang L (2018b) Nanoparticle-mediated trapping of Wnt family member 5A in tumor microenvironments enhances immunotherapy for B-Raf proto-oncogene mutant melanoma. ACS Nano 12:1250\u20131261","journal-title":"ACS Nano"},{"key":"1150_CR48","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.1073\/pnas.1222251110","volume":"110","author":"S Loi","year":"2013","unstructured":"Loi S, Pommey S, Haibe-Kains B, Beavis PA, Darcy PK, Smyth MJ, Stagg J (2013) CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer. Proc Natl Acad Sci USA 110:11091\u201311096","journal-title":"Proc Natl Acad Sci USA"},{"key":"1150_CR49","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1021\/acsnano.8b05189","volume":"12","author":"J Lu","year":"2018","unstructured":"Lu J, Liu X, Liao YP, Wang X, Ahmed A, Jiang W, Ji Y, Meng H, Nel AE (2018) Breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the IDO-1 pathway. ACS Nano 12:11041\u201311061","journal-title":"ACS Nano"},{"key":"1150_CR50","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.11.021","volume":"269","author":"EM Mastria","year":"2018","unstructured":"Mastria EM, Cai LY, Kan MJ, Li X, Schaal JL, Fiering S, Gunn MD, Dewhirst MW, Nair SK, Chilkoti A (2018) Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity. J Control Release 269:364\u2013373","journal-title":"J Control Release"},{"key":"1150_CR51","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"P Matzinger","year":"1994","unstructured":"Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991\u20131045","journal-title":"Annu Rev Immunol"},{"key":"1150_CR52","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.biotechadv.2018.04.009","volume":"36","author":"A Mazumder","year":"2018","unstructured":"Mazumder A, Cerella C, Diederich M (2018a) Natural scaffolds in anticancer therapy and precision medicine. Biotechnol Adv 36:1563\u20131585","journal-title":"Biotechnol Adv"},{"key":"1150_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2018.07.041","volume":"438","author":"A Mazumder","year":"2018","unstructured":"Mazumder A, Lee JY, Talhi O, Cerella C, Chateauvieux S, Gaigneaux A, Hong CR, Kang HJ, Lee Y, Kim KW, Kim DW, Shin HY, Dicato M, Bachari K, Silva AMS, Orlikova-Boyer B, Diederich M (2018b) Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: involvement of ER stress and DAMP release. Cancer Lett 438:197\u2013218","journal-title":"Cancer Lett"},{"key":"1150_CR54","doi-asserted-by":"publisher","first-page":"143ra199","DOI":"10.1126\/scitranslmed.3003807","volume":"4","author":"L Menger","year":"2012","unstructured":"Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, Schlemmer F, Sulpice E, Locher C, Gidrol X, Ghiringhelli F, Modjtahedi N, Galluzzi L, Andre F, Zitvogel L, Kepp O, Kroemer G (2012) Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 4:143ra199","journal-title":"Sci Transl Med"},{"key":"1150_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41418-018-0214-4","volume":"26","author":"MN Messmer","year":"2019","unstructured":"Messmer MN, Snyder AG, Oberst A (2019) Comparing the effects of different cell death programs in tumor progression and immunotherapy. Cell Death Differ 26:115\u2013129","journal-title":"Cell Death Differ"},{"key":"1150_CR56","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1126\/science.1208347","volume":"334","author":"M Michaud","year":"2011","unstructured":"Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, Ghiringhelli F, Di Virgilio F, Zitvogel L, Kroemer G (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334:1573\u20131577","journal-title":"Science"},{"key":"1150_CR57","doi-asserted-by":"publisher","first-page":"e944047","DOI":"10.4161\/21624011.2014.944047","volume":"3","author":"M Michaud","year":"2014","unstructured":"Michaud M, Xie X, Bravo-San Pedro JM, Zitvogel L, White E, Kroemer G (2014) An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology 3:e944047","journal-title":"Oncoimmunology"},{"key":"1150_CR58","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00262-011-1074-7","volume":"60","author":"R Molinari","year":"2011","unstructured":"Molinari R, D\u2019eliseo D, Manzi L, Zolla L, Velotti F, Merendino N (2011) The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure. Cancer Immunol Immunother 60:1503\u20131507","journal-title":"Cancer Immunol Immunother"},{"key":"1150_CR59","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/annonc\/mdx049","volume":"28","author":"BJ Monk","year":"2017","unstructured":"Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Coukos G (2017) A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Ann Oncol 28:996\u20131004","journal-title":"Ann Oncol"},{"key":"1150_CR60","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biotechadv.2015.03.013","volume":"33","author":"F Morceau","year":"2015","unstructured":"Morceau F, Chateauvieux S, Orsini M, Trecul A, Dicato M, Diederich M (2015) Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways. Biotechnol Adv 33:785\u2013797","journal-title":"Biotechnol Adv"},{"key":"1150_CR61","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2174\/092986712800228998","volume":"19","author":"B Orlikova","year":"2012","unstructured":"Orlikova B, Diederich M (2012) Power from the garden: plant compounds as inhibitors of the hallmarks of cancer. Curr Med Chem 19:2061\u20132087","journal-title":"Curr Med Chem"},{"key":"1150_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-642-38007-5_8","volume":"159","author":"B Orlikova","year":"2014","unstructured":"Orlikova B, Legrand N, Panning J, Dicato M, Diederich M (2014) Anti-inflammatory and anticancer drugs from nature. Cancer Treat Res 159:123\u2013143","journal-title":"Cancer Treat Res"},{"key":"1150_CR63","first-page":"122","volume":"48","author":"MZ Papa","year":"1988","unstructured":"Papa MZ, Yang JC, Vetto JT, Shiloni E, Eisenthal A, Rosenberg SA (1988) Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors. Cancer Res 48:122\u2013129","journal-title":"Cancer Res"},{"key":"1150_CR64","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ygyno.2011.05.007","volume":"122","author":"I Pellicciotta","year":"2011","unstructured":"Pellicciotta I, Yang CP, Goldberg GL, Shahabi S (2011) Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells. Gynecol Oncol 122:625\u2013631","journal-title":"Gynecol Oncol"},{"key":"1150_CR65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jss.2018.07.068","volume":"233","author":"J Qin","year":"2019","unstructured":"Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV (2019) Vaccination with mitoxantrone-treated primary colon cancer cells enhances tumor-infiltrating lymphocytes and clinical responses in colorectal liver metastases. J Surg Res 233:57\u201364","journal-title":"J Surg Res"},{"key":"1150_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcp.2018.02.006","volume":"153","author":"F Radogna","year":"2018","unstructured":"Radogna F, Diederich M (2018) Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy. Biochem Pharmacol 153:12\u201323","journal-title":"Biochem Pharmacol"},{"key":"1150_CR67","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1038\/onc.2015.455","volume":"35","author":"F Radogna","year":"2016","unstructured":"Radogna F, Cerella C, Gaigneaux A, Christov C, Dicato M, Diederich M (2016) Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma. Oncogene 35:3839\u20133853","journal-title":"Oncogene"},{"key":"1150_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bcp.2018.12.016","volume":"162","author":"F Radogna","year":"2019","unstructured":"Radogna F, Dicato M, Diederich M (2019) Natural modulators of the hallmarks of immunogenic cell death. Biochem Pharmacol 162:55\u201370","journal-title":"Biochem Pharmacol"},{"key":"1150_CR69","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1207\/s15327914nc5302_7","volume":"53","author":"LV Ramanathapuram","year":"2005","unstructured":"Ramanathapuram LV, Hahn T, Dial SM, Akporiaye ET (2005) Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination. Nutr Cancer 53:177\u2013193","journal-title":"Nutr Cancer"},{"key":"1150_CR70","doi-asserted-by":"publisher","first-page":"e60975","DOI":"10.1371\/journal.pone.0060975","volume":"8","author":"C Riganti","year":"2013","unstructured":"Riganti C, Castella B, Kopecka J, Campia I, Coscia M, Pescarmona G, Bosia A, Ghigo D, Massaia M (2013) Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells. PLoS ONE 8:e60975","journal-title":"PLoS ONE"},{"key":"1150_CR71","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.neo.2015.08.004","volume":"17","author":"J Rios-Doria","year":"2015","unstructured":"Rios-Doria J, Durham N, Wetzel L, Rothstein R, Chesebrough J, Holoweckyj N, Zhao W, Leow CC, Hollingsworth R (2015) Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models. Neoplasia 17:661\u2013670","journal-title":"Neoplasia"},{"key":"1150_CR72","doi-asserted-by":"crossref","first-page":"17631","DOI":"10.18632\/oncotarget.24815","volume":"9","author":"E Romano","year":"2018","unstructured":"Romano E, Rufo N, Korf H, Mathieu C, Garg AD, Agostinis P (2018) BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells. Oncotarget 9:17631\u201317644","journal-title":"Oncotarget"},{"key":"1150_CR73","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3390\/molecules22111932","volume":"22","author":"NFZ Schneider","year":"2017","unstructured":"Schneider NFZ, Cerella C, Simoes CMO, Diederich M (2017) Anticancer and immunogenic properties of cardiac glycosides. Molecules 22:1932","journal-title":"Molecules"},{"key":"1150_CR74","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.biotechadv.2014.03.009","volume":"32","author":"M Schnekenburger","year":"2014","unstructured":"Schnekenburger M, Dicato M, Diederich M (2014) Plant-derived epigenetic modulators for cancer treatment and prevention. Biotechnol Adv 32:1123\u20131132","journal-title":"Biotechnol Adv"},{"key":"1150_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32041","author":"M Schnekenburger","year":"2019","unstructured":"Schnekenburger M, Dicato M, Diederich MF (2019) Anticancer potential of naturally occurring immunoepigenetic modulators: a promising avenue? Cancer. https:\/\/doi.org\/10.1002\/cncr.32041","journal-title":"Cancer"},{"key":"1150_CR76","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biotechadv.2011.02.002","volume":"29","author":"M Schumacher","year":"2011","unstructured":"Schumacher M, Kelkel M, Dicato M, Diederich M (2011) Gold from the sea: marine compounds as inhibitors of the hallmarks of cancer. Biotechnol Adv 29:531\u2013547","journal-title":"Biotechnol Adv"},{"key":"1150_CR77","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1126\/science.1224922","volume":"337","author":"L Senovilla","year":"2012","unstructured":"Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, Shen S, Marino G, Criollo A, Boileve A, Job B, Ladoire S, Ghiringhelli F, Sistigu A, Yamazaki T, Rello-Varona S, Locher C, Poirier-Colame V, Talbot M, Valent A, Berardinelli F, Antoccia A, Ciccosanti F, Fimia GM, Piacentini M, Fueyo A, Messina NL, Li M, Chan CJ, Sigl V, Pourcher G, Ruckenstuhl C, Carmona-Gutierrez D, Lazar V, Penninger JM, Madeo F, Lopez-Otin C, Smyth MJ, Zitvogel L, Castedo M, Kroemer G (2012) An immunosurveillance mechanism controls cancer cell ploidy. Science 337:1678\u20131684","journal-title":"Science"},{"key":"1150_CR78","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10637-013-9984-1","volume":"31","author":"M Slingerland","year":"2013","unstructured":"Slingerland M, Cerella C, Guchelaar HJ, Diederich M, Gelderblom H (2013) Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials. Invest New Drugs 31:1087\u20131094","journal-title":"Invest New Drugs"},{"key":"1150_CR79","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.tcb.2018.05.001","volume":"28","author":"MO Steinmetz","year":"2018","unstructured":"Steinmetz MO, Prota AE (2018) Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends Cell Biol 28:776\u2013792","journal-title":"Trends Cell Biol"},{"key":"1150_CR80","doi-asserted-by":"publisher","first-page":"e28473","DOI":"10.4161\/onci.28473","volume":"3","author":"AQ Sukkurwala","year":"2014","unstructured":"Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O, Kroemer G (2014a) Screening of novel immunogenic cell death inducers within the NCI mechanistic diversity set. Oncoimmunology 3:e28473","journal-title":"Oncoimmunology"},{"key":"1150_CR81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cdd.2013.73","volume":"21","author":"AQ Sukkurwala","year":"2014","unstructured":"Sukkurwala AQ, Martins I, Wang Y, Schlemmer F, Ruckenstuhl C, Durchschlag M, Michaud M, Senovilla L, Sistigu A, Ma Y, Vacchelli E, Sulpice E, Gidrol X, Zitvogel L, Madeo F, Galluzzi L, Kepp O, Kroemer G (2014b) Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell Death Differ 21:59\u201368","journal-title":"Cell Death Differ"},{"key":"1150_CR82","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1073\/pnas.1711665115","volume":"115","author":"W Tang","year":"2018","unstructured":"Tang W, Guo Z, Cao Z, Wang M, Li P, Meng X, Zhao X, Xie Z, Wang W, Zhou A, Lou C, Chen Y (2018) d-Sedoheptulose-7-phosphate is a common precursor for the heptoses of septacidin and hygromycin B. Proc Natl Acad Sci USA 115:2818\u20132823","journal-title":"Proc Natl Acad Sci USA"},{"key":"1150_CR83","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejps.2018.10.021","volume":"127","author":"X Tang","year":"2019","unstructured":"Tang X, Rao J, Yin S, Wei J, Xia C, Li M, Mei L, Zhang Z, He Q (2019) PD-L1 knockdown via hybrid micelle promotes paclitaxel induced cancer-immunity cycle for melanoma treatment. Eur J Pharm Sci 127:161\u2013174","journal-title":"Eur J Pharm Sci"},{"key":"1150_CR84","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1021\/acschembio.8b00389","volume":"13","author":"CC Thornburg","year":"2018","unstructured":"Thornburg CC, Britt JR, Evans JR, Akee RK, Whitt JA, Trinh SK, Harris MJ, Thompson JR, Ewing TL, Shipley SM, Grothaus PG, Newman DJ, Schneider JP, Grkovic T, O\u2019keefe BR (2018) NCI program for natural product discovery: a publicly-accessible library of natural product fractions for high-throughput screening. ACS Chem Biol 13:2484\u20132497","journal-title":"ACS Chem Biol"},{"key":"1150_CR85","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2174\/0929867043455846","volume":"11","author":"R Heijden Van Der","year":"2004","unstructured":"Van Der Heijden R, Jacobs DI, Snoeijer W, Hallard D, Verpoorte R (2004) The Catharanthus alkaloids: pharmacognosy and biotechnology. Curr Med Chem 11:607\u2013628","journal-title":"Curr Med Chem"},{"key":"1150_CR86","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bbrc.2013.07.107","volume":"438","author":"T Verfaillie","year":"2013","unstructured":"Verfaillie T, Van Vliet A, Garg AD, Dewaele M, Rubio N, Gupta S, De Witte P, Samali A, Agostinis P (2013) Pro-apoptotic signaling induced by photo-oxidative ER stress is amplified by Noxa, not Bim. Biochem Biophys Res Commun 438:500\u2013506","journal-title":"Biochem Biophys Res Commun"},{"key":"1150_CR87","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013) Cancer genome landscapes. Science 339:1546\u20131558","journal-title":"Science"},{"key":"1150_CR88","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver BA (2014) How Taxol\/paclitaxel kills cancer cells. Mol Biol Cell 25:2677\u20132681","journal-title":"Mol Biol Cell"},{"key":"1150_CR89","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1021\/bi020527j","volume":"42","author":"T Weber","year":"2003","unstructured":"Weber T, Dalen H, Andera L, Negre-Salvayre A, Auge N, Sticha M, Lloret A, Terman A, Witting PK, Higuchi M, Plasilova M, Zivny J, Gellert N, Weber C, Neuzil J (2003) Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 42:4277\u20134291","journal-title":"Biochemistry"},{"key":"1150_CR90","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1423-0127-18-44","volume":"18","author":"CC Wen","year":"2011","unstructured":"Wen CC, Chen HM, Chen SS, Huang LT, Chang WT, Wei WC, Chou LC, Arulselvan P, Wu JB, Kuo SC, Yang NS (2011) Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines. J Biomed Sci 18:44","journal-title":"J Biomed Sci"},{"key":"1150_CR91","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2018.01.050","volume":"419","author":"J Wu","year":"2018","unstructured":"Wu J, Waxman DJ (2018) Immunogenic chemotherapy: dose and schedule dependence and combination with immunotherapy. Cancer Lett 419:210\u2013221","journal-title":"Cancer Lett"},{"key":"1150_CR92","doi-asserted-by":"crossref","first-page":"58754","DOI":"10.18632\/oncotarget.17678","volume":"8","author":"Q Xu","year":"2017","unstructured":"Xu Q, Chen C, Lin A, Xie Y (2017) Endoplasmic reticulum stress-mediated membrane expression of CRT\/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells. Oncotarget 8:58754\u201358764","journal-title":"Oncotarget"},{"key":"1150_CR93","doi-asserted-by":"publisher","first-page":"e50811","DOI":"10.1371\/journal.pone.0050811","volume":"7","author":"Y Yang","year":"2012","unstructured":"Yang Y, Li XJ, Chen Z, Zhu XX, Wang J, Zhang LB, Qiang L, Ma YJ, Li ZY, Guo QL, You QD (2012) Wogonin induced calreticulin\/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK\/AKT dependent manner. PLoS ONE 7:e50811","journal-title":"PLoS ONE"},{"key":"1150_CR94","doi-asserted-by":"crossref","first-page":"43629","DOI":"10.18632\/oncotarget.9660","volume":"7","author":"SY Yin","year":"2016","unstructured":"Yin SY, Efferth T, Jian FY, Chen YH, Liu CI, Wang AH, Chen YR, Hsiao PW, Yang NS (2016) Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1. Oncotarget 7:43629\u201343653","journal-title":"Oncotarget"},{"key":"1150_CR95","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrclinonc.2016.41","volume":"13","author":"L Zitvogel","year":"2016","unstructured":"Zitvogel L, Rusakiewicz S, Routy B, Ayyoub M, Kroemer G (2016) Immunological off-target effects of imatinib. Nat Rev Clin Oncol 13:431\u2013446","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-019-01150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-019-01150-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-019-01150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T17:35:40Z","timestamp":1607189740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-019-01150-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,6]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1007\/s12272-019-01150-z","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,6]]},"assertion":[{"value":"8 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}